This is the authors' abstract. We don't add key points for this paper.
In 15 out of 19 acromegalic patients, oral administration of l-dopa (500 mg) determinated a conspicuous fall in GH plasma levels. In 8 out of these 15 patients the inhibitory effect was constantly observed when the test was repeated; apomorphine administrtion (0.75 mg sc) was also followed by a significant fall (p < 0.01 at 30′–45′; p < 0.05 at 60′) of plasma levels of GH. These results are consistent with the hypothesis that the inhibitory effect of l-dopa is mediated by an activation of dopaminergic receptors at the hypothalamic or at the pituitary level. Chronic administration of l-dopa does not achieve any stable reduction of plasma GH levels because of the shortness of the inhibitory effect. l-dopa, associated with an inhibitor of decarboxylase, does not give better results.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Chiodini et al. (1974) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: